Jesmond Dalli

Jesmond Dalli is Professor in Molecular Pharmacology at the William Harvey Research Institute, part of Queen Mary University of London, where he has served as Lipid Mediator Unit Director since 2015. His research focuses on lipid mediator biology, particularly specialized pro-resolving mediators (SPMs) in inflammation, with applications spanning cardiovascular disease, arthritis, neuroinflammation, and HIV.

Education:

• PhD in Biochemical Pharmacology (2005-2009), Queen Mary University of London

His work systematically explores pro-resolving pharmacology across acute and chronic inflammation models, including diabetes, obesity, and traumatic brain injury. Articles demonstrate expertise in LC-MS/MS lipid mediator profiling, immune cell metabolism, and translational immunology.

Scientific Awards:

• Sir Henry Dale Fellowship (Royal Society & Wellcome Trust)

As Lipid Mediator Unit Director, he leads multidisciplinary studies integrating mass spectrometry platforms, cellular models, and animal models to dissect lipid mediator pathways in disease contexts.